Partner
Mitchell Mutz
Senior Principal, Samsara BioCapital
- Firm
- Samsara BioCapital
- Title
- Senior Principal
- Role
- Principal
- Known as
- Investor
Claim, correct or request removal
Record updated 4 October 2026
About
Mitchell Mutz, PhD, is a Senior Principal at Samsara BioCapital and joined in 2025. He is a successful biotech entrepreneur, venture investor, and inventor with over 25 years experience in starting and investing in biotechnology companies. Mitchell was previously Entrepreneur Partner at Vivo Capital where he led investments in EpiBiologics and Bonum Therapeutics. Prior to that, Mitchell was a Senior Investment Director at the Roche Venture Fund. Deals led included Pandion Therapeutics (acquired by Merck), Good Therapeutics (acquired by Roche), Enliven Therapeutics (NASDAQ:ELVN), and Nimble Therapeutics (acquired by Abbvie).
Is this you? Remove my profile
Loading relationship preview